Vomiting Prevention in Children With Cancer
Recruiting
N/A
Interventional Study
Chemotherapy Induced Nausea and Vomiting
Quality of Life (QOL)
Pediatric Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 1,332 (estimated)
- Sponsor
- The Hospital for Sick Children · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this single arm trial is to learn if a machine learning (ML) model predicting the risk of vomiting within the next 96 hours will impact vomiting outcomes in inpatient cancer pediatric patients.
The main questions it aims to answer are whether an ML model predicting the risk of vomiting within the next 96 hours will:
Primary
1\. Reduce the proportion with any vomiting within the 96-h…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All pediatric patients admitted to the oncology service at SickKids
Exclusion Criteria:
* Pediatric patients admitted to the oncology service at SickKids that are discharged prior to prediction time
Contacts